The use of<unk>  is uniformly associated with adverse effects. In clinical trials, the most common were nausea and vomiting, fatigue, infection, loss of appetite, and blood disorders (including anemia, thrombocytopenia, and leukopenia). It has also been associated with infections, and with metabolic disturbances (such as abnormal electrolyte levels), skin reactions, altered taste perception, and changes in cardiac electrical conduction.
Romidepsin
Lorcaserin
Palonosetron
Acetryptine
Bromopride
Cyfluthrin
Coralmyn
Tavilermide